Lower $1,000 Pill Price? We'd Love It, Says Express Scripts

(Bloomberg) -- More than two years after Express Scripts Holding Co. helped kick off a debate over U.S. pharmaceutical costs by starting a price war over Gilead Sciences Inc.’s expensive hepatitis ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.